News

For the quarter ended March 2025, Vertex (VERX) reported revenue of $177.06 million, up 12.9% over the same period last year. EPS came in at $0.15, compared to $0.15 in the year-ago quarter.

The

For the quarter ended March 2025, CDW (CDW) reported revenue of $5.2 billion, up 6.7% over the same period last year. EPS came in at $2.15, compared to $1.92 in the year-ago quarter.

The reported

Rockwell Automation (ROK) reported $2 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 5.9%. EPS of $2.45 for the same period compares to $2.50 a year

For the quarter ended March 2025, Madison Square Garden Entertainment (MSGE) reported revenue of $242.47 million, up 6.2% over the same period last year. EPS came in at $0.33, compared to $0.06 in

Teva Pharmaceutical Industries Ltd. (TEVA) reported $3.89 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.9%. EPS of $0.52 for the same period

Perrigo (PRGO) reported $1.04 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 3.5%. EPS of $0.60 for the same period compares to $0.29 a year ago.

The

Palmer Square Capital BDC Inc. (PSBD) reported $31.21 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 10.3%. EPS of $0.40 for the same period compares

For the quarter ended March 2025, Owens Corning (OC) reported revenue of $2.53 billion, up 10% over the same period last year. EPS came in at $2.97, compared to $3.59 in the year-ago quarter.

The

For the quarter ended March 2025, Johnson Controls (JCI) reported revenue of $5.68 billion, down 15.3% over the same period last year. EPS came in at $0.82, compared to $0.78 in the year-ago

For the quarter ended March 2025, Acushnet (GOLF) reported revenue of $703.37 million, down 0.6% over the same period last year. EPS came in at $1.62, compared to $1.43 in the year-ago quarter.

The

For the quarter ended March 2025, Immunocore Holdings PLC Sponsored ADR (IMCR) reported revenue of $93.88 million, up 33.2% over the same period last year. EPS came in at $0.10, compared to -$0.49

For the quarter ended March 2025, EyePoint Pharmaceuticals (EYPT) reported revenue of $24.45 million, up 109.4% over the same period last year. EPS came in at -$0.65, compared to -$0.55 in the

IPG Photonics (IPGP) reported $227.79 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 9.6%. EPS of $0.31 for the same period compares to $0.52 a year

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

From a technical perspective, CRA International (CRAI) is looking like an interesting pick, as it just reached a key level of support. CRAI recently overtook the 50-day moving average, and this

• Shares of Eli Lilly and Company LLY slid 5.6% on the session’s health care slump.
• Shares of Newmont Corporation NEM, the world's largest gold miner, jumped 3%, adding to yesterday's gains, as the